Apolipoprotein E Mutation and Double Filtration Plasmapheresis Therapy on a New Chinese Patient with Lipoprotein Glomerulopathy
Background/Aims: Lipoprotein glomerulopathy (LPG) is a rare hereditary disease. In this study, we investigated the apoE mutation and the role of double filtration plasmapheresis therapy (DFPP) on a new Chinese patient with LPG. Methods: Renal biopsy was performed on this patient to allow a definitiv...
Saved in:
Main Authors: | Wencheng Li (Author), Yang Wang (Author), Zhiwu Han (Author), Changqing Luo (Author), Chun Zhang (Author), Jing Xiong (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2014-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel apolipoprotein E mutation caused by a five amino acid deletion in a Chinese family with lipoprotein glomerulopathy: a case report
by: Weiji Xie, et al.
Published: (2019) -
Double-Filtration Plasmapheresis and High-Dose Intravenous Immunoglobulin Therapy in a Case of Anti-M Alloimmunization
by: Shun Yasuda, et al.
Published: (2024) -
Case report: Double filtration plasmapheresis (DFPP) for severe rhesus-D alloimmunization in two pregnant patients
by: Yuling Liang, et al.
Published: (2023) -
Case Report: A Pediatric Case of Lipoprotein Glomerulopathy in China and Literature Review
by: Yue Song, et al.
Published: (2021) -
Intestinal SURF4 is essential for apolipoprotein transport and lipoprotein secretion
by: Chun-Guang Guo, et al.
Published: (2024)